669
Articles
63.9K
Citations
7.3
avg. Impact Factor
129
h-index

Most Cited Articles of Cancer Immunology Program in 2009

TitleJournalYearCitations
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsNature Medicine20091.3K
Enhancing the apoptotic and therapeutic effects of HDAC inhibitorsCancer Letters2009184
Tumour suppression by p53: the importance of apoptosis and cellular senescenceJournal of Pathology2009141
The molecular basis for perforin oligomerization and transmembrane pore assemblyImmunity2009102
Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancerProceedings of the National Academy of Sciences of the United States of America2009101
Endolysosomal proteases and their inhibitors in immunityNature Reviews Immunology200999
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancerGene Therapy200991
Type I natural killer T cells suppress tumors caused by p53 loss in miceBlood200987
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapyJournal of Immunology200976
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsBlood200972
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growthPLoS ONE200970
cAMP response element binding protein is required for mouse neural progenitor cell survival and expansionStem Cells200965
Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantationNature Medicine200954
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serumJournal of Immunotherapy200947
The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activityImmunology and Cell Biology200946
Perforin-mediated suppression of B-cell lymphomaProceedings of the National Academy of Sciences of the United States of America200936
Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cellsTissue Antigens200936
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationBlood200925
CD1d activation and blockade: a new antitumor strategyJournal of Immunology200924
CD1d-based combination therapy eradicates established tumors in miceJournal of Immunology200922
Chemokine-chemokine receptors in cancer immunotherapyImmunotherapy200921
Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in MiceClinical Cancer Research200920
Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunityJournal of Immunology200917
The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cellsHaematologica200916
Genetic modification of natural killer cells for adoptive cellular immunotherapyImmunotherapy200914